Adding precision to the power of biologics through pioneering use of nanoclay gels stemming from world-class stem cell research
Adding precision to the power of biologics through pioneering use of nanoclay gels stemming from world-class stem cell research
Investment Opportunity in a Next-generation Precision Delivery Platform
Renovos is a specialist developer of RENOVITE®, a precision therapeutics delivery platform, based on synthetic nanoclay.
Renovos is an exciting opportunity for bioscience investors who share our vision of innovation supporting active living across the lifespan.
Our motivation is to unlock the full potential of therapeutics with our innovative RENOVITE® nanoclay gel technology platform, and help clinicians deliver safer and more efficacious treatments for tissue repair and beyond.
Growing market and need
Renovos’ first targets are orthobiologics and regenerative medicine, whose growth is driven by both a global ageing population and more active younger demographics damaging their tissues through sports. The RENOVITE® platform will deliver products that are easier to use and more effective, and most importantly safer.
The anticipated commercial and health economic proposition for the first product, RENOVITE® BMP-2 gel (addressing c. $1bn market), as well as following products based on the RENOVITE® platform, is clear:
the safe and rapid application of the therapeutic will reduce the incidence of failed procedures and associated revisions, allowing for an attractive price point for the product while taking significant costs out of the healthcare system
as a product injectable via a narrow gauge needle, it can further expand the addressable market by facilitating application in minimally invasive or endoscopic procedures with high precision and saving time in the theatre
the decreased risk of adverse events should allow for access to biologics for higher risk patients as well as in other procedures, which further extends the economic impact to previously unserved patient pools.
Broad Platform Technology
Bone / Cartilage
Dental
Skin
Broad Platform Technology
Bone / Cartilage
Tooth
Skin
Renovos is pioneering the use of synthetic nanoclay gels for medical use. RENOVITE® platform can be used to deliver and retain therapeutic agents, such as biologics, and promote tissue regeneration and repair in multiple applications, making step-change improvements in a wide range of current procedures.
RENOVITE® enables: